Shandong Lukang Pharmaceutical Co Ltd (600789.SS)
18 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|2018||Chairman of the Board, General Manager|
|51||2018||Chief Financial Officer, Finance Director|
|46||2011||Deputy General Manager, Director|
|54||2013||Deputy General Manager, Director|
|50||2011||Deputy General Manager, Director|
- BRIEF-Shandong Lukang Pharmaceutical receives supporting fund of 12.3 mln yuan
- China stocks end lower as trade war fears weigh
- Hong Kong stocks fall as trade war fears resurface; China steady
- Shanghai shares see worst month since early 2016
- BRIEF-Shandong Lukang Pharmaceutical Receives Land Compensation Of 484 Mln Yuan